TOKYO -- Fujifilm Holdings aims to roughly double sales in its health care business to crack 1 trillion yen ($9.24 billion) in the next several years, seeking to build a new reliable income driver as its mainstay copier business stagnates.
Biotechnology
Fujifilm's Komori says health care can double to $10bn business
CEO sees M&A boosting scale while mainstay copier operations slow down
Fujifilm Holdings CEO Shigetaka Komori sees regenerative medicine making strong contributions to earnings in several years. (Photo by Yasunori Okamura)
Read Next
Latest on Biotechnology
